SomaLogic chooses board member Alister Reynolds as new company CEO

SomaLogic chooses board member Alister Reynolds as new company CEO

BOULDER -- SomaLogic announced that Board of Directors member Alister W. (Al) Reynolds has agreed to become the next company CEO. Reynolds replaces Byron Hewett , who elected to... Read More

Thursday April 6, 2017 0 comments Tags: Boulder, SomaLogic, Alister Reynolds, Byron Hewett, Larry Gold

SomaLogic raises up to $60.5 million from Visium Healthcare Partners to support growth initiatives

SomaLogic raises up to $60.5 million from Visium Healthcare Partners to support growth initiatives

BOULDER -- SomaLogic, Inc . and New York-based Visium Healthcare Partners today announced SomaLogic will receive up to $60.5 million through a combination of debt and equity financing from... Read More

Tuesday March 1, 2016 0 comments Tags: Boulder, SomaLogic, Visium Healthcare Partners, Byron Hewett, Larry Gold

SomaLogic adds Matthew Norkunas as new CFO

SomaLogic adds Matthew Norkunas as new CFO

BOULDER -- SomaLogic , Inc., announced Matthew Norkunas , M.D., has joined the company as chief financial officer. We are excited that Matt has agreed to join us during this critical... Read More

Wednesday February 10, 2016 0 comments Tags: SomaLogic, Byron Hewett, Boulder, Matthew Norkunas

SomaLogic partners with University of Oxford to advance protein biomarker discovery, clinical testing

SomaLogic partners with University of Oxford to advance protein biomarker discovery, clinical testing

BOULDER -- SomaLogic and the University of Oxford today announced they have agreed to collaborate on a number of projects that will employ SomaLogics proprietary SOMAmer reagents and SOMAscan ... Read More

Monday February 8, 2016 0 comments Tags: SomaLogic, Byron Hewett, Boulder, SOMAscan, SOMAmer reagents

INterview with Byron Hewett, CEO of SomaLogic

INterview with Byron Hewett, CEO of SomaLogic

Byron Hewetthas been CEOof SomaLogicsince December 2013. SomaLogicis a Boulder-based life sciences company focused on aiding in the discovery and development of new diagnostics and... Read More

Tuesday January 26, 2016 0 comments Tags: Byron Hewett, Boulder, SomaLogic

SomaLogic signs agreement to enhance Bristol-Myers Squibb’s drug discovery research

SomaLogic signs agreement to enhance Bristol-Myers Squibb’s drug discovery research

BOULDER -- SomaLogic Inc . announced it has signed an agreement with the Bristol-Myers Squibb Company (NYSE: BMY) to provide expanded access to its proprietary SOMAer reagents. The agreement... Read More

Tuesday January 12, 2016 0 comments Tags: Boulder, SomaLogic, SOMAmer reagents, Byron Hewett, Bristol-Myers Squibb

SomaLogic launches larger commercial version of SOMAscan proteomic assay

SomaLogic launches larger commercial version of SOMAscan proteomic assay

BOULDER --SomaLogic announced the latest version of its proprietary SOMAscan proteomic assayis now commercially available to the life science research community. Called SOMAscan Assay 1.3k,... Read More

Thursday September 24, 2015 0 comments Tags: SomaLogic, SOMAscan, Byron Hewett, Boulder

SomaLogic and Otsuka Pharma extend collaboration agreement

SomaLogic and Otsuka Pharma extend collaboration agreement

BOULDER -- SomaLogic announced it has extended its initial collaboration agreement with Japan-based Otsuka Pharmaceutical Co. Ltd. in the development of several SOMAmer therapeutics. ... Read More

By: InnovatioNews Tuesday August 11, 2015 0 comments Tags: Boulder, SomaLogic, Byron Hewett, Otsuka Pharmaceutica, SOMAmer reagents